GleanMark is free for all of AprilGet free access
ALKERMES PHARMA IRELAND LIMITED logo

ALKERMES PHARMA IRELAND LIMITED

77 Marks
Corp.
First Filed:Oct 15, 1996Latest Filed:Jun 30, 2022Address:1 Burlington Road, Dublin 4, IE

Portfolio Overview

Registered
21(27%)
Dead
56(73%)
Previous
10

Top Classes

Class 5
Pharmaceuticals
63(82%)
Class 44
Medical, beauty and agricultural services
5(6%)
Class 36
Insurance, Financial Services & Real Estate
3(4%)

TTAB Proceedings

Total Proceedings
3
As Plaintiff
0(0%)
As Defendant
3(100%)

Top Firms

Foley & Lardner LLP(Oct 2023)
75
Hamilton, Brook, Smith & Rey...(May 2012)
8
PEPPER HAMILTON LLP(Feb 2015)
2
FINNEGAN, HENDERSON, FARABOW...(Jun 2017)
1

Trademark Activity Timeline(1996 – 2026)

Trademark Portfolio

87 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
RANQELTA
RANQELTA
Trademark
Word
ABANDONED
Owner:
Serial:97484402
Filed:Jun 30, 2022
Classes:5
ARISTADA
ARISTADA
Service Mark
Combined
REGISTERED
Owner:
Serial:90765853
Filed:Jun 10, 2021
Classes:35
Registration:6818095
Registered:Aug 16, 2022
Goods & Services
Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms; appointment reminder services being support services for patients and for health care providers on behalf of their patients | Providing information about pharmacies, namely, providing a database featuring information about insurance coverage for pharmaceuticals in the nature of pharmacy selection based on patient health plan coverage requirements; providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs | Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes | Support services for health care providers and their patients in the nature of providing patient advocate and case management services, namely, coordinating the procurement of medication in the nature of coordinating with pharmacies to facilitate prescription fulfillment; providing patient advocate and case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement and administration of medication in the nature of locating health care providers that can prescribe and administer prescribed medication
ARISTADA
ARISTADA
Service Mark
Word
REGISTERED
Owner:
Serial:90765846
Filed:Jun 10, 2021
Classes:36
Registration:6818094
Registered:Aug 16, 2022
Goods & Services
Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms; appointment reminder services being support services for patients and for health care providers on behalf of their patients | Providing information about pharmacies, namely, providing a database featuring information about insurance coverage for pharmaceuticals in the nature of pharmacy selection based on patient health plan coverage requirements; providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs | Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes | Support services for health care providers and their patients in the nature of providing patient advocate and case management services, namely, coordinating the procurement of medication in the nature of coordinating with pharmacies to facilitate prescription fulfillment; providing patient advocate and case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement and administration of medication in the nature of locating health care providers that can prescribe and administer prescribed medication
LYBALVI
LYBALVI
Service Mark
Combined
REGISTERED
Owner:
Serial:90765843
Filed:Jun 10, 2021
Classes:35, 36, 44, +1
Registration:8111271
Registered:Jan 20, 2026
Goods & Services
Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms | Providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs | Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes | Support services for health care providers and their patients in the nature of providing case management services, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program; providing case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program
LYBALVI
LYBALVI
Service Mark
Word
REGISTERED
Owner:
Serial:90765835
Filed:Jun 10, 2021
Classes:35, 36, 44, +1
Registration:8111270
Registered:Jan 20, 2026
Goods & Services
Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms | Providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs | Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes | Support services for health care providers and their patients in the nature of providing case management services, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program; providing case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program
LYBALVI
LYBALVI
Trademark
Word
ABANDONED
Owner:
Serial:90538254
Filed:Feb 22, 2021
Classes:5
XONELITY
XONELITY
Trademark
Word
ABANDONED
Owner:
Serial:90460424
Filed:Jan 12, 2021
Classes:5
PUSH BACK AGAINST YOUR BIPOLAR DISORDER
Owner:
Serial:90178694
Filed:Sep 14, 2020
Classes:41
Goods & Services
"BIPOLAR DISORDER"
PUSH BACK AGAINST YOUR SCHIZOPHRENIA
ABANDONED
Owner:
Serial:90178739
Filed:Sep 14, 2020
Classes:41
Goods & Services
"SCHIZOPHRENIA"
ELUMIDOR
ELUMIDOR
Trademark
Word
ABANDONED
Owner:
Serial:88876477
Filed:Apr 17, 2020
Classes:5
RELUMIDOR
RELUMIDOR
Trademark
Word
ABANDONED
Owner:
Serial:88876512
Filed:Apr 17, 2020
Classes:5
KEEP THE BODY IN MIND
KEEP THE BODY IN MIND
Service Mark
Word
REGISTERED
Owner:
Serial:88626472
Filed:Sep 23, 2019
Classes:41
Registration:6041768
Registered:Apr 28, 2020
Goods & Services
Providing awareness programs in the nature of educational presentations for health care practitioners in the field of managing people living with a serious mental illness, including schizophrenia and bipolar disorder
LYBALVI
LYBALVI
Trademark
Combined
REGISTERED
Owner:
Serial:88489837
Filed:Jun 26, 2019
Classes:5
Registration:6913410
Registered:Nov 29, 2022
Goods & Services
Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia
88420585
88420585
Trademark
Design
REGISTERED
Owner:
Serial:88420585
Filed:May 8, 2019
Classes:5
Registration:6687304
Registered:Mar 29, 2022
Goods & Services
Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia
UNITED FOR SCHIZOPHRENIA
UNITED FOR SCHIZOPHRENIA
Service Mark
Word
REGISTERED
Owner:
Serial:88385817
Filed:Apr 15, 2019
Classes:44, 45
Registration:5957731
Registered:Jan 7, 2020
Goods & Services
Providing a website featuring emotional support information and personal stories on the subjects of treating and supporting patients and families living with schizophrenia; Providing educational information in the field of schizophrenia
RANQELTA
RANQELTA
Trademark
Word
ABANDONED
Owner:
Serial:88196664
Filed:Nov 16, 2018
Classes:5
ELUMASSIST
ELUMASSIST
Service Mark
Combined
ABANDONED
Owner:
Serial:88194836
Filed:Nov 15, 2018
Classes:44
ELUMASSIST
ELUMASSIST
Service Mark
Word
ABANDONED
Owner:
Serial:88015199
Filed:Jun 26, 2018
Classes:44
ARISTADA
ARISTADA
Trademark
Combined
REGISTERED
Owner:
Serial:87806402
Filed:Feb 22, 2018
Classes:5
Registration:5519704
Registered:Jul 17, 2018
Goods & Services
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases
LYBALVI
LYBALVI
Trademark
Word
REGISTERED
Owner:
Serial:87700839
Filed:Nov 29, 2017
Classes:5
Registration:6428572
Registered:Jul 20, 2021
Goods & Services
Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia
NUQLARIS
NUQLARIS
Trademark
Word
ABANDONED
Owner:
Serial:87700836
Filed:Nov 29, 2017
Classes:5
XONELITY
XONELITY
Trademark
Word
ABANDONED
Owner:
Serial:87522017
Filed:Jul 10, 2017
Classes:5
ENDORFICA
ENDORFICA
Trademark
Word
ABANDONED
Owner:
Serial:87486031
Filed:Jun 13, 2017
Classes:5
ENDORIQUE
ENDORIQUE
Trademark
Word
ABANDONED
Owner:
Serial:87486032
Filed:Jun 13, 2017
Classes:5
RELUMINATE
RELUMINATE
Trademark
Word
ABANDONED
Owner:
Serial:87486030
Filed:Jun 13, 2017
Classes:5
MAYLOTRA
MAYLOTRA
Trademark
Word
ABANDONED
Owner:
Serial:87476958
Filed:Jun 6, 2017
Classes:5
VANZENTRO
VANZENTRO
Trademark
Word
ABANDONED
Owner:
Serial:87476928
Filed:Jun 6, 2017
Classes:5
ARIFIRST
ARIFIRST
Trademark
Word
ABANDONED
Owner:
Serial:87424262
Filed:Apr 25, 2017
Classes:5
ARINITIO
ARINITIO
Trademark
Word
ABANDONED
Owner:
Serial:87424282
Filed:Apr 25, 2017
Classes:5
COMMENZADA
COMMENZADA
Trademark
Word
ABANDONED
Owner:
Serial:87424298
Filed:Apr 25, 2017
Classes:5
ARISTADA COMENZA
ARISTADA COMENZA
Trademark
Word
ABANDONED
Owner:
Serial:87276114
Filed:Dec 21, 2016
Classes:5
ARISTADA INITIO
ARISTADA INITIO
Trademark
Word
REGISTERED
Owner:
Serial:87276061
Filed:Dec 21, 2016
Classes:5
Registration:5581432
Registered:Oct 9, 2018
Goods & Services
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
ARISTADA NEO
ARISTADA NEO
Trademark
Word
ABANDONED
Owner:
Serial:87276093
Filed:Dec 21, 2016
Classes:5
ELUMIDOR
ELUMIDOR
Trademark
Word
ABANDONED
Owner:
Serial:87271227
Filed:Dec 16, 2016
Classes:5
RELUMIDOR
RELUMIDOR
Trademark
Word
ABANDONED
Owner:
Serial:87271250
Filed:Dec 16, 2016
Classes:5
87189089
87189089
Trademark
Design
REGISTERED
Owner:
Serial:87189089
Filed:Sep 30, 2016
Classes:5
Registration:5392593
Registered:Jan 30, 2018
Goods & Services
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
ARISTADA
ARISTADA
Trademark
Combined
REGISTERED
Owner:
Serial:87189103
Filed:Sep 30, 2016
Classes:5
Registration:5392594
Registered:Jan 30, 2018
Goods & Services
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
ARLIANCE
ARLIANCE
Trademark
Word
ABANDONED
Owner:
Serial:87047963
Filed:May 24, 2016
Classes:5
LONSARIS
LONSARIS
Trademark
Word
ABANDONED
Owner:
Serial:86817594
Filed:Nov 12, 2015
Classes:5
TRUBEAD
TRUBEAD
Trademark
Word
ABANDONED
Owner:
Serial:86470151
Filed:Dec 3, 2014
Classes:5
PEOTEK
PEOTEK
Trademark
Word
ABANDONED
Owner:
Serial:86452078
Filed:Nov 12, 2014
Classes:5
POLIBEAD
POLIBEAD
Trademark
Word
ABANDONED
Owner:
Serial:86452118
Filed:Nov 12, 2014
Classes:5
TRIBEAD
TRIBEAD
Trademark
Word
ABANDONED
Owner:
Serial:86452099
Filed:Nov 12, 2014
Classes:5
BEHALTRA
BEHALTRA
Trademark
Word
ABANDONED
Owner:
Serial:86444125
Filed:Nov 4, 2014
Classes:5
ONTRADA
ONTRADA
Trademark
Word
ABANDONED
Owner:
Serial:86444122
Filed:Nov 4, 2014
Classes:5
SOLINADE
SOLINADE
Trademark
Word
ABANDONED
Owner:
Serial:86444118
Filed:Nov 4, 2014
Classes:5
SUSTAMID
SUSTAMID
Trademark
Word
ABANDONED
Owner:
Serial:86444108
Filed:Nov 4, 2014
Classes:5
VIXIA
VIXIA
Trademark
Word
ABANDONED
Owner:
Serial:86444113
Filed:Nov 4, 2014
Classes:5
VIXOR
VIXOR
Trademark
Word
ABANDONED
Owner:
Serial:86444112
Filed:Nov 4, 2014
Classes:5
VYAMID
VYAMID
Trademark
Word
ABANDONED
Owner:
Serial:86444115
Filed:Nov 4, 2014
Classes:5
86388950
86388950
Trademark
Design
CANCELLED
Owner:
Serial:86388950
Filed:Sep 9, 2014
Classes:5
Registration:4942167
Registered:Apr 19, 2016
ARISTADA
ARISTADA
Trademark
Combined
CANCELLED
Owner:
Serial:86388951
Filed:Sep 9, 2014
Classes:5
Registration:4942168
Registered:Apr 19, 2016
AMPLARI
AMPLARI
Trademark
Word
ABANDONED
Owner:
Serial:85619263
Filed:May 8, 2012
Classes:5
ARIDELIS
ARIDELIS
Trademark
Word
ABANDONED
Owner:
Serial:85619268
Filed:May 8, 2012
Classes:5
ARISTADA
ARISTADA
Trademark
Word
REGISTERED
Owner:
Serial:85619287
Filed:May 8, 2012
Classes:5
Registration:4893254
Registered:Jan 26, 2016
Goods & Services
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
ARLIANCE
ARLIANCE
Trademark
Word
ABANDONED
Owner:
Serial:85619270
Filed:May 8, 2012
Classes:5
EXTENARI
EXTENARI
Trademark
Word
ABANDONED
Owner:
Serial:85619280
Filed:May 8, 2012
Classes:5
LONSARI
LONSARI
Trademark
Word
ABANDONED
Owner:
Serial:85619275
Filed:May 8, 2012
Classes:5
LONSARIS
LONSARIS
Trademark
Word
ABANDONED
Owner:
Serial:85619283
Filed:May 8, 2012
Classes:5
MONARI
MONARI
Trademark
Word
ABANDONED
Owner:
Serial:85619273
Filed:May 8, 2012
Classes:5
BEHALTRA
BEHALTRA
Trademark
Word
ABANDONED
Owner:
Serial:85305466
Filed:Apr 26, 2011
Classes:5
Goods & Services
Pharmaceutical preparations and compounds, namely small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, reward disorders, treatment refractory depression, binge eating disorder, weight gain, CNS disorders, pain and constipation
ONTRADA
ONTRADA
Trademark
Word
ABANDONED
Owner:
Serial:85305465
Filed:Apr 26, 2011
Classes:5
Goods & Services
Pharmaceutical preparations and compounds, namely small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, reward disorders, treatment refractory depression, binge eating disorder, weight gain, CNS disorders, pain and constipation
SOLINADE
SOLINADE
Trademark
Word
ABANDONED
Owner:
Serial:85305458
Filed:Apr 26, 2011
Classes:5
Goods & Services
Pharmaceutical preparations and compounds, namely small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, reward disorders, treatment refractory depression, binge eating disorder, weight gain, CNS disorders, pain and constipation
SUSTAMID
SUSTAMID
Trademark
Word
ABANDONED
Owner:
Serial:85305453
Filed:Apr 26, 2011
Classes:5
Goods & Services
Pharmaceutical preparations and compounds, namely small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, reward disorders, treatment refractory depression, binge eating disorder, weight gain, CNS disorders, pain and constipation
VIXIA
VIXIA
Trademark
Word
ABANDONED
Owner:
Serial:85305457
Filed:Apr 26, 2011
Classes:5
Goods & Services
Pharmaceutical preparations and compounds, namely small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, reward disorders, treatment refractory depression, binge eating disorder, weight gain, CNS disorders, pain and constipation
VIXOR
VIXOR
Trademark
Word
ABANDONED
Owner:
Serial:85305454
Filed:Apr 26, 2011
Classes:5
Goods & Services
Pharmaceutical preparations and compounds, namely small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, reward disorders, treatment refractory depression, binge eating disorder, weight gain, CNS disorders, pain and constipation
VYAMID
VYAMID
Trademark
Word
ABANDONED
Owner:
Serial:85305460
Filed:Apr 26, 2011
Classes:5
Goods & Services
Pharmaceutical preparations and compounds, namely small molecules and chemical compounds for use in opioid modulation; Pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, reward disorders, treatment refractory depression, binge eating disorder, weight gain, CNS disorders, pain and constipation
LINKERX
LINKERX
Trademark
Word
REGISTERED
Owner:
Serial:77906658
Filed:Jan 7, 2010
Classes:5
Registration:3955579
Registered:May 3, 2011
Goods & Services
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of the aforesaid diseases
MXDAS
MXDAS
Trademark
Word
REGISTERED
Owner:
Serial:77422501
Filed:Mar 14, 2008
Classes:5
Registration:3796256
Registered:Jun 1, 2010
Goods & Services
Pharmaceutical preparations, namely, a drug delivery system comprising a polymer-based matrix, in an oral dosage form, for the continuous and/or controlled release of a wide variety of therapeutic agents
MEDISORB
MEDISORB
Trademark
Word
REGISTERED
Owner:
Serial:77055168
Filed:Dec 1, 2006
Classes:1
Registration:3427573
Registered:May 13, 2008
Goods & Services
Synthetic biodegradable polymers for use in the manufacture of [ surgical sutures, surgical staples, surgical clips, scaffolds for growing cells or tissues, ] materials and devices for use in drug delivery [, and other medical and industrial products ]
POLYMILL
POLYMILL
Trademark
Word
REGISTERED
Owner:
Serial:78551624
Filed:Jan 21, 2005
Classes:3
Registration:3070610
Registered:Mar 21, 2006
Goods & Services
Polystyrene milling media for the fine particulate grinding of pharmaceuticals
CODAS
CODAS
Trademark
Word
REGISTERED
Owner:
Serial:78538974
Filed:Dec 28, 2004
Classes:5
Registration:3591236
Registered:Mar 17, 2009
Goods & Services
Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the systematic, controlled and continuous release of a wide variety of therapeutic agents
NANOMILL
NANOMILL
Trademark
Word
CANCELLED
Owner:
Serial:78227711
Filed:Mar 19, 2003
Classes:7
Registration:3246086
Registered:May 29, 2007
Goods & Services
Chemical processing apparatus, namely, machines for grinding, mixing, agitating and/or making chemicals for industrial and commercial use
SODAS
SODAS
Trademark
Word
CANCELLED
Owner:
Serial:78127040
Filed:May 8, 2002
Classes:5
Registration:2794607
Registered:Dec 16, 2003
Goods & Services
Release agents sold as an integral component of pharmaceutical preparations for use in the treatment of pain and/or neurological conditions
NANOMILL
NANOMILL
Trademark
Word
CANCELLED
Owner:
Serial:75939970
Filed:Mar 9, 2000
Classes:7
Registration:2867038
Registered:Jul 27, 2004
Goods & Services
Machines for grinding particulate matter in the nature of pharmaceuticals, pharmaceutical formulations and diagnostic imaging agents
NANOCRYSTAL
NANOCRYSTAL
Trademark
Word
REGISTERED
Owner:
Serial:75425872
Filed:Jan 29, 1998
Classes:5
Registration:2386089
Registered:Sep 12, 2000
Goods & Services
Pharmaceutical preparations, namely, adjuvant preparations sold as a component of a full line of pharmaceuticals, and ingredients and components thereof, namely ultra-small particle formulations
MEDISORB
MEDISORB
Trademark
Word
REGISTERED
Owner:
Serial:75181721
Filed:Oct 15, 1996
Classes:5
Registration:2217667
Registered:Jan 12, 1999
Goods & Services
polymer-based drug delivery formulations for clinical use
ARQIMLY
ARQIMLY
Trademark
Word
Previous
ITU
PENDING
Owner:
Serial:98210373
Filed:Oct 5, 2023
Classes:1, 5, 42, +1
Goods & Services
Biopharmaceutical active substances, namely, pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; Biological preparations for the treatment of cancer; Engineered fusion proteins for medical diagnostic and treatment purposes, namely, engineered fusion proteins created through the use of circular permutation technology for use in the treatment of cancer and cancer-related disorders; Engineered interleukin protein pharmaceutical preparations for use in optimizing patients' immune cellular response to prevent cancer-associated morbidity and mortality; Pharmaceutical preparations, namely, tumor-targeted immunotherapeutic fusion proteins for the treatment of cancer and cancer-related disorders; Cytokine inhibitory pharmaceutical and biological preparations for use in the treatment of oncology-related diseases and disorders; Biological and chemical immunotherapy preparations comprising anti-body-cytokine fusion protein pharmaceutical preparations for use in the medical treatment and prevention of cancer; Therapeutic proteins for use in the manufacture of pharmaceutical preparations; Providing educational information in the field of medication treatment for oncology to health care providers and patients, namely, providing information in the field of cancer prevention, screening, diagnosis and treatment; Research and development of medicines for use in the fields of oncology-related diseases and disorders; Protein engineering for others for use in the development of pharmaceuticals; Protein structure modifications for others for use in the development of pharmaceuticals, namely, conducting pharmaceutical research and development of engineered protein therapeutic pharmaceuticals and biopharmaceuticals for others; Conducting medical and scientific research in the fields of oncology-related diseases and disorders for others; Conducting clinical medical research for others in the field of cancerous diseases and disorders; Clinical research in the field of cancerous diseases and disorders in the nature of research and development of pharmaceuticals and biopharmaceutical products for others; Scientific research in the field of cancerous diseases and disorders in the nature of research and development of pharmaceuticals and biopharmaceutical products for others; Providing information and data about medical and scientific research and development in the fields of pharmaceuticals, biopharmaceuticals, clinical trials, therapeutic proteins, and fusion proteins, used to treat cancerous diseases and disorders; Providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; Cytokine engineering and cytokine research and development for use in the development of pharmaceuticals, namely, conducting pharmaceutical research, engineering and products development for others in the fields of cancer, immunopharmaceuticals for use in the treatment of cancer and engineered cytokine therapeutic pharmaceuticals and bio-pharmaceuticals for use in the treatment of cancer and cancer-related disorders; Conducting scientific research for others in the field of cytokine biology for use in pharmaceutical research and development; Scientific research and development of immune modulating proteins for others for use in the development of pharmaceuticals; Scientific research and development for others of cytokine based biopharmaceutical treatments for oncology-related diseases and disorders; Conducting protein based therapeutic medical research and pharmaceutical products development for others in the field of pharmaceuticals and biopharmaceuticals for the treatment of cancer and related diseases and disorders; Protein or cytokine based cancer immunotherapy research and development, namely, conducting pharmaceutical research and products development for others in the field of cancer; Providing educational information in the field of medication treatment for oncology to health care providers and patients, namely, providing medical and scientific research information about clinical trials featuring pharmaceutical treatments in the field of oncology
NEMCASGO
NEMCASGO
Trademark
Word
Previous
ABANDONED
Owner:
Serial:98210397
Filed:Oct 5, 2023
Classes:1, 5, 42, +1
Goods & Services
Biopharmaceutical active substances, namely, pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; Biological preparations for the treatment of cancer; Engineered fusion proteins for medical diagnostic and treatment purposes, namely, engineered fusion proteins created through the use of circular permutation technology for use in the treatment of cancer and cancer-related disorders; Engineered interleukin protein pharmaceutical preparations for use in optimizing patients' immune cellular response to prevent cancer-associated morbidity and mortality; Pharmaceutical preparations, namely, tumor-targeted immunotherapeutic fusion proteins for the treatment of cancer and cancer-related disorders; Cytokine inhibitory pharmaceutical and biological preparations for use in the treatment of oncology-related diseases and disorders; Biological and chemical immunotherapy preparations comprising anti-body-cytokine fusion protein pharmaceutical preparations for use in the medical treatment and prevention of cancer; Therapeutic proteins for use in the manufacture of pharmaceutical preparations; Providing educational information in the field of medication treatment for oncology to health care providers and patients, namely, providing information in the field of cancer prevention, screening, diagnosis and treatment; Research and development of medicines for use in the fields of oncology-related diseases and disorders; Protein engineering for others for use in the development of pharmaceuticals; Protein structure modifications for others for use in the development of pharmaceuticals, namely, conducting pharmaceutical research and development of engineered protein therapeutic pharmaceuticals and biopharmaceuticals for others; Conducting medical and scientific research in the fields of oncology-related diseases and disorders for others; Conducting clinical medical research for others in the field of cancerous diseases and disorders; Clinical research in the field of cancerous diseases and disorders in the nature of research and development of pharmaceuticals and biopharmaceutical products for others; Scientific research in the field of cancerous diseases and disorders in the nature of research and development of pharmaceuticals and biopharmaceutical products for others; Providing information and data about medical and scientific research and development in the fields of pharmaceuticals, biopharmaceuticals, clinical trials, therapeutic proteins, and fusion proteins, used to treat cancerous diseases and disorders; Providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; Cytokine engineering and cytokine research and development for use in the development of pharmaceuticals, namely, conducting pharmaceutical research, engineering and products development for others in the fields of cancer, immunopharmaceuticals for use in the treatment of cancer and engineered cytokine therapeutic pharmaceuticals and bio-pharmaceuticals for use in the treatment of cancer and cancer-related disorders; Conducting scientific research for others in the field of cytokine biology for use in pharmaceutical research and development; Scientific research and development of immune modulating proteins for others for use in the development of pharmaceuticals; Scientific research and development for others of cytokine based biopharmaceutical treatments for oncology-related diseases and disorders; Conducting protein based therapeutic medical research and pharmaceutical products development for others in the field of pharmaceuticals and biopharmaceuticals for the treatment of cancer and related diseases and disorders; Protein or cytokine based cancer immunotherapy research and development, namely, conducting pharmaceutical research and products development for others in the field of cancer; Providing educational information in the field of medication treatment for oncology to health care providers and patients, namely, providing medical and scientific research information about clinical trials featuring pharmaceutical treatments in the field of oncology
TELDAZIA
TELDAZIA
Trademark
Word
Previous
ABANDONED
Owner:
Serial:98210357
Filed:Oct 5, 2023
Classes:1, 5, 42, +1
Goods & Services
Biopharmaceutical active substances, namely, pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; Biological preparations for the treatment of cancer; Engineered fusion proteins for medical diagnostic and treatment purposes, namely, engineered fusion proteins created through the use of circular permutation technology for use in the treatment of cancer and cancer-related disorders; Engineered interleukin protein pharmaceutical preparations for use in optimizing patients' immune cellular response to prevent cancer-associated morbidity and mortality; Pharmaceutical preparations, namely, tumor-targeted immunotherapeutic fusion proteins for the treatment of cancer and cancer-related disorders; Cytokine inhibitory pharmaceutical and biological preparations for use in the treatment of oncology-related diseases and disorders; Biological and chemical immunotherapy preparations comprising anti-body-cytokine fusion protein pharmaceutical preparations for use in the medical treatment and prevention of cancer; Therapeutic proteins for use in the manufacture of pharmaceutical preparations; Providing educational information in the field of medication treatment for oncology to health care providers and patients, namely, providing information in the field of cancer prevention, screening, diagnosis and treatment; Research and development of medicines for use in the fields of oncology-related diseases and disorders; Protein engineering for others for use in the development of pharmaceuticals; Protein structure modifications for others for use in the development of pharmaceuticals, namely, conducting pharmaceutical research and development of engineered protein therapeutic pharmaceuticals and biopharmaceuticals for others; Conducting medical and scientific research in the fields of oncology-related diseases and disorders for others; Conducting clinical medical research for others in the field of cancerous diseases and disorders; Clinical research in the field of cancerous diseases and disorders in the nature of research and development of pharmaceuticals and biopharmaceutical products for others; Scientific research in the field of cancerous diseases and disorders in the nature of research and development of pharmaceuticals and biopharmaceutical products for others; Providing information and data about medical and scientific research and development in the fields of pharmaceuticals, biopharmaceuticals, clinical trials, therapeutic proteins, and fusion proteins, used to treat cancerous diseases and disorders; Providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; Cytokine engineering and cytokine research and development for use in the development of pharmaceuticals, namely, conducting pharmaceutical research, engineering and products development for others in the fields of cancer, immunopharmaceuticals for use in the treatment of cancer and engineered cytokine therapeutic pharmaceuticals and bio-pharmaceuticals for use in the treatment of cancer and cancer-related disorders; Conducting scientific research for others in the field of cytokine biology for use in pharmaceutical research and development; Scientific research and development of immune modulating proteins for others for use in the development of pharmaceuticals; Scientific research and development for others of cytokine based biopharmaceutical treatments for oncology-related diseases and disorders; Conducting protein based therapeutic medical research and pharmaceutical products development for others in the field of pharmaceuticals and biopharmaceuticals for the treatment of cancer and related diseases and disorders; Protein or cytokine based cancer immunotherapy research and development, namely, conducting pharmaceutical research and products development for others in the field of cancer; Providing educational information in the field of medication treatment for oncology to health care providers and patients, namely, providing medical and scientific research information about clinical trials featuring pharmaceutical treatments in the field of oncology